Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Access Protocol of Denosumab for Subjects with Advanced Cancer
2011-002114-36Phase 3Completed
- Sponsor
- Amgen
- Start
- Aug 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of denosumab in bone metastases, breast cancer and prostate cancer (PCa), sponsored by Amgen. Started Aug 2011; status: completed.
02
Drugs
denosumab
03
Conditions
bone metastasesbreast cancerprostate cancer (PCa)
Beyond the preview
Go deeper on 2011-002114-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002114-36.